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Bicoid (Bcd) is a morphogenetic protein that instructs patterning along the anterior-posterior (A-P) axis in Drosophila melanogaster embryos. Despite extensive studies, what controls the formation of a normal concentration gradient of Bcd remains an unresolved and controversial question. Here, we show that Bcd protein degradation is mediated by the ubiquitin-proteasome pathway. We have identified an F-box protein, encoded by fates-shifted (fsd), that has an important role in Bcd protein degradation by targeting it for ubiquitylation. Embryos from females lacking fsd have an altered Bcd gradient profile, resulting in a shift of the fatemap along the A-P axis. Our study is an experimental demonstration that, contrary to an alternative hypothesis, Bcd protein degradation is required for normal gradient formation and developmental fate determination.
Morphogens are molecules that form concentration gradients in a developing embryo or tissue to provide positional information to cells and instruct their developmental fates [1] [2] [3] [4] [5] . The Drosophila morphogenetic protein Bicoid (Bcd) forms a concentration gradient along the anterior-posterior (A-P) axis of the embryo and instructs patterning by activating its downstream target genes in a concentration-dependent manner [6] [7] [8] [9] . An important question about morphogens relates to the molecular mechanisms that control the formation of a normal gradient. Diffusion and degradation of morphogen molecules are two physical properties critical to both the process of gradient formation and the final outcome of the gradient 1, 5, 10, 11 . Although the diffusion constant for Bcd molecules in embryos remains highly controversial [12] [13] [14] , what controls Bcd degradation remains virtually unknown at this time. In this report, we investigate the molecular mechanisms of Bcd protein degradation. We present evidence that Bcd degradation is required for the formation of a normal concentration gradient in embryos and for instructing cells to adopt their normal developmental fates.
REsults

Bcd degradation in Drosophila cells is sensitive to proteasome inhibitors
We generated Drosophila S2 cells that stably express a haemagglutinin (HA)-tagged wild-type Bcd protein from the actin promoter. Western blotting analysis confirmed the expression of the full-length Bcd protein in these cells ( Supplementary Information, Fig. S1a ). This HA-Bcd protein can activate transcription of a Bcd-dependent reporter gene in S2 cells 15 , demonstrating that it is functionally active. To investigate mechanisms and pathways of Bcd protein degradation, we treated the cells stably expressing HA-Bcd with various inhibitors. The proteasome inhibitor MG132 increased the total amount of Bcd (Fig. 1a, lane 4 and Supplementary Information, Fig. S1b ). Neither Z-LL-H, which is an MG132 analogue and a calpain inhibitor, nor chloroquine diphosphate, which is a lysosome inhibitor, had such an effect (Fig. 1a, lanes 2 and  3) . Two additional proteasome inhibitors, lactacystin and epoxomicin, which inhibit proteasome activities through distinct mechanisms 16, 17 , also increased the total amount of Bcd (Fig. 1a, lanes 5 and 6) . These results suggest that the proteasome-dependent pathway is important for Bcd protein degradation.
Bcd degradation in Drosophila embryonic extracts reveals a role for ubiquitin
To further investigate Bcd degradation mechanisms, we generated Drosophila embryonic extracts from embryos at 0-3 h. An HA-Bcd fusion protein was efficiently degraded in these extracts (Fig. 1b , lanes 1-6), but such degradation was significantly inhibited by MG132 (Fig.  1b, lanes [7] [8] [9] [10] [11] [12] or epoxomicin ( Supplementary Information, Fig. S1c,  d ). Bcd degradation profiles in the presence or absence of MG132 both fitted well with the first order decay function 18 (Fig. 1c) , with a respective Adjusted R 2 value of 0.999 and 0.981. MG132 extends the estimated half-life of Bcd by 13.10-fold (± 1.80; n = 3 from experiments performed as in Fig. 1b, c) . These results further support our conclusion that Bcd is degraded in a proteasome-dependent manner.
Proteins destined for proteasome-mediated degradation are often polyubiquitylated [19] [20] [21] [22] . Unlike protein degradation in the lysosome, ubiquitylation is a process that requires energy from ATP hydrolysis 22 . We therefore investigated whether Bcd degradation in embryonic extracts is dependent on ATP. Addition of ATP into the embryonic extracts enhanced Bcd degradation, with a 61% reduction in the estimated half-life of Bcd ( Fig. 2a,  b ). In addition, depletion of ATP from the extracts through the use of hexokinase and glucose led to the attenuation of Bcd degradation (Fig. 2c,  d) , extending the estimated half-life of Bcd by 2.3-fold.
To directly investigate the role of ubiquitin in Bcd degradation, we used a mutant ubiquitin, UM-N0K, which has all of its seven lysine residues mutated to arginines. This mutant ubiquitin can prevent polyubiquitylation and inhibit ubiquitin-dependent protein degradation 23 . If Bcd degradation is indeed dependent on polyubiquitylation, we would expect this mutant ubiquitin to inhibit Bcd degradation. Our results show that when UM-N0K was added to the embryonic extracts Bcd degradation was attenuated ( Fig. 2e , f), extending its estimated half-life by 1.93-fold (s.d. ± 0.35, n = 3 experiments performed as in Fig. 2e , f). Together, these results suggest that Bcd is degraded in a proteasome-and ubiquitin-dependent manner.
Bcd is ubiquitylated
To determine whether Bcd is ubiquitylated, we performed an in vivo ubiquitylation assay in human embryonic kidney (HEK) 293T cells, which have an efficient ubiquitylation system 24 . To increase the amount of ubiquitinmodified products, a ubiquitin-expressing plasmid was co-transfected into these cells, which were then treated with MG132 before harvest. As shown in Figure 2g , ubiquitin-modified Bcd protein species (lane 4) were detected in a Bcd-and MG132-dependent manner (see other lanes for controls). These results support the hypothesis that Bcd is ubiquitylated.
Identifying an F-box protein involved in Bcd degradation
Ubiquitylation is catalysed by three stepwise enzymatic reactions, with the ubiquitin ligase E3 providing substrate specificity [19] [20] [21] [22] . One group of E3 ligases, the SCF (Skp1-Cul1/Cdc53-F-box protein)-type E3 ligases, have a role in the turnover of many transcription factors [25] [26] [27] [28] [29] [30] . The substrate specificity in these multi-protein complexes is conferred by F-box proteins 25, 31, 32 . We performed a double-stranded RNA interference (dsRNAi) screen for 38 potential Drosophila F-box proteins in the S2 cells stably expressing HA-Bcd. The addition of dsRNA targeting the fates-shifted (fsd, CG12765) gene caused a consistent increase in the total amount of Bcd ( Supplementary  Information, Fig. S2a , lane 3; see lanes 1 and 2 for specificity). Next, we used cycloheximide (CHX) to block translation in the HA-Bcd-expressing stable cells ( Fig. 3a ) and found that fsd dsRNA treatment increased the estimated half-life of Bcd by 1.5-fold ( Fig. 3b ). In addition, overexpressing Fsd in S2 cells reduced the total amount of Bcd (42%; Fig. 3c , lane 2; see lanes 1 and 3 for controls). These results indicate that Fsd has an important role in regulating Bcd protein stability in Drosophila cells.
Fsd is an F-box protein that directly interacts with both skp1 and Bcd Based on the alignment of the 234 sequences used to create the F-box profile in the Pfam database, F-box motifs are highly degenerate, lacking a strict primary consensus sequence 31 . Our alignment of all potential F-box domains in Drosophila derived from the Interpro database further confirms the degenerate nature of the primary sequences of the F-box motif ( Supplementary Information, Fig. S3 ). A hallmark of a genuine F-box protein is its ability to interact with Skp1, another component of the SCF complex 25, 31, 32 . To determine if Fsd has this property, we performed co-immunoprecipitation experiments using HEK 293T cells. HA-Skp1 was specifically co-precipitated with Flag-Fsd (Fig. 4a , lane 6; see other lanes for controls), demonstrating that Fsd and Skp1 can physically interact with each other in cells.
To further evaluate the role of Skp1 in Bcd degradation, we manipulated Skp1 protein levels in the HA-Bcd-expressing stable cells. The total amount of Bcd in these cells was decreased when additional Skp1 (Flag-Skp1) was expressed ( Supplementary Information, Fig. S2b , lane 3; see lane 1 for control). As expected, MG132, which inhibits the downstream step of protein degradation, increased the total amount of Bcd to a similar level regardless of the status of additional Skp1 expression ( Supplementary Information,  Fig. S2b, lanes 1-4) . In addition, when cells were treated with skpA dsRNA, the estimated half-life of Bcd was extended by 2.5-fold (Supplementary Information, Fig. S2c, d ). These results suggest that both Fsd and Skp1 participate in the Bcd degradation process, presumably working together in a novel Fsd-containing SCF (SCF Fsd ) E3 ligase.
F-box proteins target their substrates for degradation by recruiting them, through direct protein-protein interactions, to the SCF E3 ligase complexes for ubiquitylation 25, 31, 32 . To determine whether Bcd is a substrate of the proposed SCF Fsd E3 ligase, we performed another co-immunoprecipitation experiment. Our results indicate that HA-Bcd was specifically co-precipitated by Flag-Fsd (Fig. 4b , lane 6; see other lanes for controls), demonstrating that Fsd can physically interact with Bcd. Therefore Fsd seems to be a bona fide F-box protein that can directly interact with both a component (Skp1) within the proposed SCF Fsd complex and its substrate Bcd.
Embryos lacking Fsd exhibit posterior shifts in morphological and molecular markers Sequence analysis of an fsd cDNA clone (NM_137007.3) predicted a protein of 312 amino acids, with two potential F-box domains (Fig. 5a ). Fsd does not seem to contain any other conserved domains. fsd transcripts are uniformly distributed in both preblastoderm and gastrulated embryos ( Supplementary Information, Fig. S4a, b ), suggesting both maternal and zygotic expression. We obtained a publically available Drosophila line with a P-element insertion that disrupts the fsd gene, referred to as fsd KG02393 . We confirmed that the insertion is 15 bp downstream of ATG, which effectively disrupts the entire open reading frame (Fig. 5a ). The fsd KG02393 flies are homozygous viable, but exhibit a temperature-dependent hatching defect. Although the hatching rates of embryos from wild-type and fsd KG02393 flies were comparable at 25 °C (91.3% versus 81.7%, Supplementary  Information, Fig. S4c ), embryos from mutant flies had a significantly reduced hatching rate at 18 °C (48.6%, compared with 92% for wild-type). At 29 °C, embryos from fsd KG02393 females (referred to as fsd embryos from now on) had a hatching rate of 0%. Cuticle examination detected mutant embryos with variable A-P patterning defects when incubated at 29 °C, including missing/fused denticle bands ( Supplementary Information, Fig.  S5b-d ). Whole-mount in situ hybridization analysis also detected mutant embryos with abnormal even-skipped (eve) expression patterns with missing or fused stripes ( Supplementary Information, Fig. S5f, g) . These results suggest that the hatching defect observed at 29 °C is a consequence of A-P patterning defects caused by the fsd mutation. The hatching defect at 29 °C is strictly associated with the maternal mutant genotype (data not shown) and, furthermore, mutant flies at non-optimal temperatures (18 °C) do not exhibit a significant reduction in survival rates from larvae to pupae or from pupae to adults ( Supplementary Information, Fig. S4c ). These results suggest that the primary function of fsd is conferred maternally to embryos.
Acting as a morphogen instructing A-P patterning, the amount of Bcd directly controls the fatemap of the entire embryo along the A-P axis [33] [34] [35] . If Fsd has a role in promoting Bcd protein degradation in embryos as observed in our in vitro assays, fsd embryos may exhibit a posterior shift of the fatemap reflective of an altered amount of Bcd. To directly evaluate this possibility, we measured the position of the cephalic furrow, a morphological marker along the A-P axis and a strong indicator of Bcd protein levels in embryos 13, 34, 36 . For experiments described from now on, all embryos were collected at 25 °C (unless stated otherwise) to avoid any temperature influence on Bcd gradient formation and embryonic patterning. Figure 5b , c indicates that the cephalic furrow position (in fractional embryo length, x/L) was shifted from 0.343 ± 0.005 (n = 10) in wild-type embryos to 0.372 ± 0.012 (n = 9) in fsd embryos (P = 4.6 × 10 -6 , Student's t-test). To evaluate the effect of the fsd gene mutation on embryonic patterning at the molecular level, we measured the expression pattern of eve 37 using quantitative fluorescence in situ hybridization (FISH). To ensure a direct comparison, experiments and data processing for wildtype and mutant embryos were performed side-by-side. Figure 5d demonstrates the mean expression profiles of eve in wild-type and mutant embryos, revealing a posterior shift for all eve stripes in fsd embryos (see Supplementary Information Fig. S6a , b for raw data). For example, the first eve stripe is shifted from 0.331 ± 0.014 (n = 7) in wild-type embryos to 0.353 ± 0.009 (n = 8) in fsd embryos (P = 3.9 × 10 -3 , Fig. 5d ).
To trace the origin of the observed fatemap shift in mutant embryos, we measured expression patterns of the gap genes hunchback (hb) and knirps (kni), both of which are direct targets of Bcd 8, [38] [39] [40] [41] [42] [43] [44] . Again, we conducted side-by-side experiments in wild-type and mutant embryos for each gene in our quantitative FISH experiments. As shown in Figure 5e , f, the expression boundaries of both gap genes exhibited a significant posterior shift in fsd embryos (see Supplementary Information, Fig. 6c -f for raw data). Specifically, the hb expression boundary had a posterior shift of approximately 3% of the embryo length, from a x/L of 0.450 ± 0.008 (n = 8) in wild-type embryos to 0.479 ± 0.018 (n = 7) in fsd embryos (P = 1.4 × 10 -3 , Fig. 5e ). The kni expression boundary was shifted toward the posterior by approximately 2% of the embryo length, from 0.671 ± 0.010 (n = 9) in wild-type embryos to 0.689 ± 0.017 (n = 8) in fsd embryos (P = 1.3 × 10 -2 , Fig. 5f ). These results demonstrate that a maternal loss of fsd function results in a posterior shift of both morphological and molecular markers along the A-P axis.
fsd and bcd interact genetically The observed fatemap shift in fsd embryos is supportive of a direct role of Fsd in targeting Bcd for degradation in embryos. To further test this hypothesis, we conducted a genetic interaction analysis in embryos from bcd E1 /+ females that are either wild-type or mutant for fsd. Our results show that the anterior fatemap shift caused by maternal bcd dosage reduction is rescued partially by eliminating fsd maternally ( Supplementary Information, Fig. S7a-c) . These results demonstrate an interaction, genetically, between fsd and bcd in regulating developmental fate specification along the A-P axis.
fsd embryos have an altered Bcd gradient profile To directly determine whether Fsd has a role in Bcd gradient formation, we conducted a quantitative immunostaining analysis using anti-Bcd antibodies on whole-mount wild-type and mutant embryos 45 . For this analysis we used raw, unprocessed Bcd fluorescence intensity data within a linear range, with background intensities directly measured under identical experimental conditions. Figure 6a, b show Bcd intensity (B) data extracted from individual wild-type and fsd embryos that were stained, imaged and analysed side-by-side. Also shown in these figures are the measured background intensities. To evaluate the shape of the Bcd gradient profiles, we calculated and compared the length constant (λ) values of either the average Bcd profiles from wild-type and mutant embryos or values from individual embryos. In a simple diffusion model 1, 5, 46 , λ of an exponential profile is a function of the effective diffusion coefficient (D) and the effective degradation rate of the morphogen molecules (ω): λ 2 = D/ω. As Bcd protein itself has not been altered in fsd embryos, D is expected to remain unaffected by fsd mutation, which allows us to estimate the relative ω values in wild-type and mutant embryos based on the measured λ values. Figure 6c shows a ln (B/B max ) plot as a function of A-P position x/L. Both B and B max are from average Bcd profiles of wild-type and fsd embryos and are background subtracted (as necessary) without any further adjustments. The ln transformation converts an exponential function to a linear function 42 . Here, we perform a linear fit within the range of x/L 0.1 to 0.5, where the Bcd intensity data are least sensitive to experimental and background measurement errors 45, 46 . We also exclude data from the most anterior part of the embryo where Bcd profiles are known to deviate from an exponential function 10, 42, 45 . The linear fitting (Fig. 6c ) had a smaller slope in fsd embryos than in wildtype embryos, suggesting a larger λ value in fsd embryos. To further compare Bcd profiles, we calculated λ values for individual wild-type and mutant embryos (Fig. 6d ). The calculated λ values increased from 78.94 ± 12.93 μm (n = 25) in wild-type embryos to 95.95 ± 14.03 μm (n = 28) in fsd embryos (P = 3.22 × 10 -5 , Fig. 6d ). These results (and Fig. 5 and Supplementary Information, Fig. S6 ) provide in vivo evidence that Fsd has a role in regulating Bcd protein stability and determining developmental fates along the A-P axis.
DIscussIOn
Advancing the morphogen concept requires an understanding of not only how cells respond to the positional information encoded by the morphogen gradients, but also how such gradients are established. According to a widely accepted view 1 , the formation of a concentration gradient requires a localized source of morphogen production, coupled with diffusion and degradation of the morphogen molecules. However, recent studies question whether the formation of a normal concentration gradient of Bcd in embryos requires either diffusion or decay of Bcd molecules 47, 48 . Before our current work, it was not known how Bcd molecules are degraded, making it difficult to evaluate the role of Bcd protein degradation in gradient formation in vivo. We report for the first time that Bcd is degraded through the ubiquitin-proteasome pathway. The identification of a novel F-box gene, fsd, makes it possible to experimentally perturb Bcd degradation in vivo and investigate its role on Bcd gradient formation and developmental fate determination. The Bcd gradient profile in fsd embryos has a larger λ value than in wildtype embryos, demonstrating that, contrary to a recent proposal 47 , Bcd degradation is required for normal gradient formation. Our observed difference in λ values corresponds to, in a simple diffusion model, an approximately 48% increase in Bcd stability in fsd embryos, a difference sufficient to cause significant shifts in morphological and molecular markers ( Fig. 5 ). We note that, unlike λ, B max in wild-type and fsd embryos did not exhibit a significant difference (44.32 ± 9.10 and 42.53 ± 9.19, respectively, P = 0.63, Student's t-test). Like λ, the steady-state amount of morphogen molecules at the source is also a function of D and ω in a simple diffusion model, but this amount is additionally dependent on the morphogen production rate J 1,5,46 . As the Bcd production site (that is, bcd mRNA location) is not restricted to a single point as assumed in the idealized simple diffusion model 10 , λ should represent a more reliable parameter (than, for example, B max ) in evaluating the relative effective degradation rates of Bcd.
The hb expression boundary in fsd embryos exhibits a shift toward the posterior by approximately 3% of the embryo length. This is consistent with the shift of the positional information encoded by the Bcd gradient in fsd embryos (Fig. 6e ). These results, together with those presented elsewhere 45, 46, 49 , demonstrate that the hb expression boundary is primarily determined by the positional information provided by the Bcd gradient. Although gene regulatory networks represent important mechanisms for maintaining or refining gene expression patterns 11, 46, 50, 51 , our results suggest that early decisions in A-P patterning, such as hb expression, are controlled primarily by the positional information encoded by the Bcd gradient. The hb boundary shift of approximately 3% of the embryo length in fsd embryos matches the observed cephalic furrow shift (approximately 3% of the embryo length), indicating that early decisions in gene expression are faithfully passed down to the morphological level. We note that the hb boundary shift in fsd embryos, though seemingly modest, is significant when compared with the observed shift (approximately 7% of the embryo length) caused by the doubling of the maternal bcd gene dose to four copies 42 . A shift of approximately 3% of the embryo length, when expressed in absolute length, is comparable to the difference between our measured λ values in wild-type and mutant embryos. We also note that the fatemap shift in fsd embryos was detected at 25 °C. The hatching defect of fsd embryos at 29 °C represents a manifestation of more severe A-P patterning defects ( Supplementary Information, Fig. S5 ), probably reflective of the complex effects of temperature on both Bcd gradient formation (that is, degradation and diffusion) and other relevant processes. Finally, we note that the fsd KG02393 allele used throughout our work is probably a null allele because it is indistinguishable from an allele, fsd [5] [6] [7] , that has the entire fsd coding sequence deleted ( Supplementary Information,  Fig. S8 ). SCF E3 ligases regulate many biological processes, such as DNA replication, transcription, signal transduction, cell proliferation and death, and tissue growth and patterning 25, 26, 31, 32 . Our study identifies an F-box protein (encoded by fsd) that has a role in Bcd gradient formation and developmental fate specification. Our study thus expands the list of biological processes that SCF E3 ligases regulate. Fsd directly interacts with both its substrate Bcd and an SCF component Skp1, suggesting that Bcd is targeted for degradation by an Fsd-containing SCF complex, SCF Fsd , that functions as an E3 ubiquitin ligase. We currently do not know whether Fsd may have other substrates. Identification of additional substrates of Fsd, if any, will provide a more comprehensive understanding of the biological functions of this F-box protein.
How a normal Bcd concentration gradient is formed in early embryos remains an open question currently under intense debate 10, 13, 14, [47] [48] [49] 52, 53 . One particular aspect of the debate focuses on the roles of the nucleus. Although some studies suggest that nuclei have important roles in Bcd degradation 7 and proper gradient formation 13, 54 , others suggest that the shaping of a normal Bcd gradient is independent of nuclei 55 . Fsd is broadly distributed in cells with a primary localization to the cytoplasm ( Supplementary  Information, Figs. S4d-f) , consistent with the notion that cytoplasm has a role in Bcd degradation. However, our recent studies have shown that dCBP, a Bcd-interacting transcription cofactor 56, 57 , affects Bcd gradient profile in embryos 46 , suggesting that nuclei also contribute to Bcd degradation and gradient formation. Although efficient Bcd degradation requires Fsd both in vitro and in vivo, we consider it unlikely that SCF Fsd is the only E3 ligase for Bcd. Identifying additional E3 ligases, particularly those with a primary localization to the nucleus, should help settle the ongoing controversy regarding the role of nuclei in Bcd gradient formation.
MEtHODs
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturecellbiology/ MEtHODs Fly lines, plasmids and cells. The fsd KG02393 flies were obtained from the Bloomington Drosophila Stock Center (stock number 12983). The following vectors were used in this study. pGEM3 (Promega) was used as a template for in vitro transcription/translation. The pAc5.1/V5-His C vector (Invitrogen) containing the Drosophila actin 5C promoter was used to constitutively express proteins in Drosophila S2 cells. The pcDNA3 vector (Invitrogen) containing the human Cytomegalovirus immediate-early (CMV) promoter was used for over-expressing proteins in HEK 293T cells. All plasmids used in this study were generated by standard cloning methods. Drosophila S2 and HEK 293T cells were cultured in Schneider's Drosophila medium (Invitrogen) and Dulbecco's modification of Eagle's medium (Cellgro), respectively, both containing 10% (v/v) fetal calf serum (Invitrogen) and 1 × antibiotic-antimycotic (Invitrogen). Transfection in both cells was performed using the FuGENE HD transfection reagent (Roche) according to the manufacturer's instructions.
Stable Drosophila S2 cells and protein stability assay. Drosophila S2 cells that stably express HA-Bcd were generated as described previously 58 . The following is a list of inhibitors (sources; final concentrations) for treating cells: chloroquine diphosphate (Sigma; 500 μM), Z-LL-H (Peptides International; 100 μM), MG132 (Boston Biochem; 75 μM), lactacystin (Calbiochem; 10 μM), epoxomicin (Calbiochem; 300 nM), and CHX (Sigma; 100 μg ml -1 ). For transient assays, a lacZ reporter was used to normalize transfection efficiency 15 .
Protein degradation assay in Drosophila embryonic extracts. Drosophila embryonic extracts (extracted from w1118 embryos at 0-3 h) were prepared as described previously 59 , diluted to a final concentration of 10 mg ml -1 and stored at -80 °C before use. HA-Bcd protein used in protein degradation assays was translated in vitro using the T N T quick coupled transcription/translation system (Promega). Degradation reactions were performed at 30 °C, with or without the following (at given final concentrations): MG132 (500 μM), epoxomicin (100 μM), Mg-ATP (Boston Biochem; 5 mM), UM-N0K (Boston Biochem, 0.67 μg μl -1 ), glucose (Sigma; 10 mM) and hexokinase (Sigma; 0.3 U μl -1 ). We have noticed that the protein degradation activities of the stored embryonic extracts varied somewhat. Thus, all kinetic experiments with specific treatments included a side-by-side (at all steps) no-treatment control. Only comparisons between side-by-side assays are meaningful and, thus, no comparisons were made (or should be made) between experiments. Despite this variability, the effects of different treatments on Bcd stability are highly reproducible between independent experiments.
Western blot and protein quantifications. For detecting total protein amounts in cells, cells were directly boiled in 1 × SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) loading buffer (50 mM Tris-HCl at pH 6.8, 100 mM dithiothreitol, 2% SDS, 10% glycerol and 0.1% bromophenol blue) for 8 min, with a brief vortexing every 2 min. Proteins were separated by SDS-PAGE and transferred to Immun-Blot PVDF (polyvinylidene fluoride) membrane (Bio-Rad) for western blotting using appropriate primary antibodies and HRP (horse radish peroxidase)conjugated secondary antibodies. Western blotting signals were visualized by ECL (enhanced chemiluminsescence) plus Western blotting detection reagents (GE Healthcare). HA-tagged and Flag-tagged proteins were detected by anti-HA (Covance) and anti-Flag (Sigma) primary antibodies, respectively; anti-β-actin antibody (Abcam) was used to detect β-actin as loading control whenever necessary. anti-HA (1:1,000), anti-flag (1:1,000) and anti-β-actin (1:2,000). The protein bands detected in western blotting were quantified as follows. X-ray films were scanned with the HP Scanjet 4070 Photosmart scanner, followed by analysis using the Scion image software. A rectangular box of the same size was chosen to cover the individual bands of interest, with mean intensities determined by the software. In vivo ubiquitylation and co-immunoprecipitation assays. For ubiquitylation assay, the HA-Bcd-expressing plasmid was transiently transfected into HEK 293T cells, along with a second plasmid expressing a Flag-tagged ubiquitin. Cell lysates were prepared and incubated with anti-HA monoclonal antibody (Roche) and protein G Sepharose 4 fast flow beads (GE Healthcare). Immunoprecipitates were resolved by SDS-PAGE and western blotting was performed using anti-ubiquitin antibody (Zymed 1:500). For co-immunoprecipitation assays, HEK 293T cells were co-transfected with plasmids expressing Flag-Fsd and HA-Skp1 (or HA-Bcd). Cell lysates were incubated with anti-Flag antibody (Sigma) and protein G Sepharose 4 fast flow beads, followed by western blotting using indicated antibodies. dsRNAi generation and screening in the HA-Bcd-expressing stable S2 cells. For dsRNAi screening 60 , 38 potential Drosophila F-box proteins were determined from the Interpro database from the European Bioinformatics Institute. Primers used for PCR amplification of each gene fragment were chosen from the amplicon database of the Drosophila RNAi Screening Center at Harvard Medical School. To transcribe dsRNAs in vitro from the PCR fragments, each primer contained a T7 RNA polymerase binding site (5ʹ-TAATACGACTCACTATAGGG-3ʹ) at 5ʹ. The dsRNAs were generated from the MEGASCRIPT T7 transcription kit (Ambion) and purified by the RNeasy mini kit (Qiagen). To minimize the effect of plate-to-plate variations and increase the reliability of assays during screening, fold change in Bcd levels for each sample was calculated by dividing the intensity of a sample by the mean of all of the 12 samples on a given plate, with all experimental and quantification steps performed strictly on a side-by-side basis for all samples on a single plate.
Embryo staining, imaging and intensity measurement. Embryos were collected at 0-4 h at the stated temperatures, fixed and stained for mRNA using digoxigenin (Roche)-labelled antisense RNA probe as previously described 61, 62 with the following modifications: embryos were post-fixed with 10% (v/v) formaldehyde (Fisher Scientific) and hybridization was performed in a buffer containing 0.3% SDS (40 h incubation) without protease K pre-treatment. Cy3-AffiniPure Donkey anti-mouse immunoglobulin G (IgG; Jackson ImmunoResearch) was used as the secondary antibody. Imaging and quantification were described previously 45 , with all images captured within a linear range under identical settings in a single image cycle (for both wild-type and mutant embryos that were stained for a gene of interest) to minimize measurement errors. To measure the FISH intensities in the cytoplasm, a circular window 61 pixels in size was used to slide along the embryo edge immediately outside of the nuclear layer (basally for hb and kni; apically for eve) during the automated image processing. It has been shown that gap gene and segmentation gene expression patterns evolve during nuclear cycle 14 (refs 50, 63) . To minimize such effects and allow accurate comparison between wild-type and mutant embryos, we selected embryos within short developmental windows with a peak expression level for each gene analysed. Specifically, we selected embryos at early nuclear cycle 14 with a nuclear height:width ratio of 1.3:1 to 1.7:1 for hb and kni expression patterns, as described previously 45 . For hb expression, embryos were further selected to have a posterior hb expression at a normalized level between 0.25 and 0.75. For kni expression, embryos were further selected to ensure no detectable expression stripe at the x/L position of approximately 0.25. The segmentation gene eve reaches its peak expression at a later time than the gap genes, and we selected embryos at a stage (before the onset of gastrulation) shown to have highly precise eve pattern 63 . To further increase the precision of developmental time for eve analysis, we selected embryos that had the seventh stripe level > 75% of the first stripe level. The measured boundary positions for all three genes were highly precise within each group of embryos, with a standard deviation that is less than that of the observed posterior shifts between wild-type and fsd embryos in each case.
Embryo staining, imaging and intensity measurements with anti-Bcd antibodies (Santa Cruz Biotechnology) were as described previously 45 . To compare λ val-λ val-values of Bcd profiles from wild-type and fsd embryos, we first analysed their mean Bcd intensity profiles as a function of x/L. Bcd intensities used in this analysis were background-subtracted without further adjustments. The linear fit of ln (B/B max ) was conducted using the Matlab software. The λ values in individual embryos were calculated as described 45 . In an alternative fitting, we used the equation of B = B max e -x/λ + C and obtained consistent results; the mean λ values calculated from Bcd profiles of individual wild-type and fsd embryos are 75.08 ± 9.90 μm and 94.20 ± 16.41 μm (P = 5.9 × 10 -6 ), respectively.
Immunocytochemistry. Drosophila S2 cells were cultured on a Lab-Tek II chamber slide and transfected with the HA-Fsd-expressing plasmid. Cells were fixed, permeabilized, incubated with anti-HA antibody (1:100 dilution) and Alexa [5] [6] [7] flies are homozygous viable at 25°C but embryos fail to hatch at 29°C. The measured CF positions for wt embryos and embryos from fsd [5] [6] [7] females (referred to fsd [5] [6] [7] embryos; all results shown in this figure were obtained at 25°C) are 0.347 ± 0.009 (n = 9) and 0.376 ± 0.013 (n = 13), respectively (p = 9.9 × 10 -6 ). (b and c) Normalized FISH intensity data for hb extracted from individual wt (b) and fsd [5] [6] [7] (c) embryos. (d) Average hb intensity profiles from b and c. The mean hb boundary positions in wt and fsd [5] [6] [7] embryos are 0.447 ± 0.015 (n = 9) and 0.475 ± 0.011 (n = 10), respectively (p = 1.7×10 -4 ). 
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